We then re-estimated key components of the tumor immune microenvironment, including the MHC (antigen presentation capacity), EC (effector cells), SC (immune suppressor cells), CP (immune checkpoints), AZ (antigen zones or areas of immune activation) and the IPS (Immunophenoscore) infiltration scores per patient and tumor using gene expression data, summarizing the tumor’s overall immunogenic profile. Here, HLA-C is linked to neoplasm.